Masahide Yazaki

4.9k total citations
158 papers, 3.3k citations indexed

About

Masahide Yazaki is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Masahide Yazaki has authored 158 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Molecular Biology, 35 papers in Physiology and 26 papers in Surgery. Recurrent topics in Masahide Yazaki's work include Amyloidosis: Diagnosis, Treatment, Outcomes (83 papers), Metabolism and Genetic Disorders (25 papers) and Alzheimer's disease research and treatments (18 papers). Masahide Yazaki is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (83 papers), Metabolism and Genetic Disorders (25 papers) and Alzheimer's disease research and treatments (18 papers). Masahide Yazaki collaborates with scholars based in Japan, United States and China. Masahide Yazaki's co-authors include Shu‐ichi Ikeda, Merrill D. Benson, Yoshiki Sekijima, Fuyuki Kametani, Akinori Nakamura, Jun Koyama, Takahiko Tokuda, Juris J. Liepnieks, Tsuneaki Yoshinaga and Masayuki Matsuda and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Masahide Yazaki

153 papers receiving 3.3k citations

Peers

Masahide Yazaki
Carlos R. Ferreira United States
Frank A. Carone United States
John R. Woollard United States
Jun Zhan China
Carlos R. Ferreira United States
Masahide Yazaki
Citations per year, relative to Masahide Yazaki Masahide Yazaki (= 1×) peers Carlos R. Ferreira

Countries citing papers authored by Masahide Yazaki

Since Specialization
Citations

This map shows the geographic impact of Masahide Yazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahide Yazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahide Yazaki more than expected).

Fields of papers citing papers by Masahide Yazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahide Yazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahide Yazaki. The network helps show where Masahide Yazaki may publish in the future.

Co-authorship network of co-authors of Masahide Yazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Masahide Yazaki. A scholar is included among the top collaborators of Masahide Yazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahide Yazaki. Masahide Yazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ow, Jin Rong, Eri Imagawa, Feng Chen, et al.. (2025). Developing splice-switching oligonucleotides for urea cycle disorder using an integrated diagnostic and therapeutic platform. Journal of Hepatology. 83(2). 411–425. 2 indexed citations
2.
3.
Katoh, Nagaaki, Fuyuki Kametani, Masahide Yazaki, et al.. (2024). Enterocolic granulomatous phlebitis associated with epidermal growth factor‐containing fibulin‐like extracellular matrix protein 1 deposition and focal amyloid properties: A case report. Pathology International. 74(3). 146–153. 4 indexed citations
4.
Takahashi, Yusuke, Minori Kodaira, Mitsunori Yamada, et al.. (2023). Anterior horn damage in brachial multisegmental amyotrophy with superficial siderosis and dural tear: an autopsy case report. BMC Neurology. 23(1). 129–129. 2 indexed citations
5.
Kishida, Dai, Masahide Yazaki, Akinori Nakamura, et al.. (2017). One novel and two uncommon MEFV mutations in Japanese patients with familial Mediterranean fever: a clinicogenetic study. Rheumatology International. 38(1). 105–110. 4 indexed citations
6.
Sawashita, Jinko, Eri Ishikawa, Mu Yang, et al.. (2017). Comprehensive proteomic profiles of mouse AApoAII amyloid fibrils provide insights into the involvement of lipoproteins in the pathology of amyloidosis. Journal of Proteomics. 172. 111–121. 14 indexed citations
7.
Manabe, Shun, et al.. (2015). Renal AH Amyloidosis Associated With a Truncated Immunoglobulin Heavy Chain Undetectable by Immunostaining. American Journal of Kidney Diseases. 66(6). 1095–1100. 15 indexed citations
8.
Migita, Kiyoshi, Kazunaga Agematsu, Masahide Yazaki, et al.. (2014). Familial Mediterranean Fever. Medicine. 93(3). 158–164. 66 indexed citations
9.
Komatsu, Michiharu, Takefumi Kimura, Masahide Yazaki, et al.. (2014). Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(3). 473–481. 62 indexed citations
10.
Migita, Kiyoshi, Ritei Uehara, Yoshikazu Nakamura, et al.. (2012). Familial Mediterranean Fever in Japan. Medicine. 91(6). 337–343. 85 indexed citations
11.
Yazaki, Masahide, Shu‐ichi Ikeda, Keiko Kobayashi, & Takeyori Saheki. (2010). Therapeutic approaches for patients with adult-onset type II citrullinemia (CTLN2): effectiveness of treatment with low-carbohydrate diet and sodium pyruvate. Rinsho Shinkeigaku. 50(11). 844–847. 13 indexed citations
12.
Tsuchiya‐Suzuki, Ayako, Masahide Yazaki, Fuyuki Kametani, Yoshiki Sekijima, & Shu‐ichi Ikeda. (2010). Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Human Pathology. 42(2). 236–243. 16 indexed citations
13.
Noto, Yu‐ichi, Takahiko Tokuda, Kensuke Shiga, et al.. (2009). Cardiomyopathy in a Japanese family with the Glu61Lys transthyretin variant: a new phenotype. Amyloid. 16(2). 99–102. 6 indexed citations
14.
Katoh, Nagaaki, Masayuki Matsuda, Takuhiro Yoshida, et al.. (2009). Primary AL amyloid polyneuropathy successfully treated with high‐dose melphalan followed by autologous stem cell transplantation. Muscle & Nerve. 41(1). 138–143. 15 indexed citations
15.
Nakamura, Akinori, Kunihiro Yoshida, Kazuhiro Fukushima, et al.. (2008). Follow-up of three patients with a large in-frame deletion of exons 45–55 in the Duchenne muscular dystrophy (DMD) gene. Journal of Clinical Neuroscience. 15(7). 757–763. 68 indexed citations
16.
Yazaki, Masahide, et al.. (2004). MRI analysis on a patient with the V30M mutation is characteristic of leptomeningeal amyloid. Amyloid. 11(4). 265–267. 10 indexed citations
17.
Connors, Lawreen H., Taro Yamashita, Masahide Yazaki, Martha Skinner, & Merrill D. Benson. (2004). A rare transthyretin mutation (Asp18Glu) associated with cardiomyopathy. Amyloid. 11(1). 61–66. 15 indexed citations
18.
Yazaki, Masahide, Sandra A. Farrell, & Merrill D. Benson. (2003). A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. Kidney International. 63(5). 1652–1657. 89 indexed citations
19.
Yazaki, Masahide, John Varga, P. James B. Dyck, & Merrill D. Benson. (2002). A new transthyretin variant Leu55Gln in a patient with systemic amyloidosis. Amyloid. 9(4). 268–271. 10 indexed citations
20.
Benson, Merrill D., Juris J. Liepnieks, Masahide Yazaki, et al.. (2001). A New Human Hereditary Amyloidosis: The Result of a Stop-Codon Mutation in the Apolipoprotein AII Gene. Genomics. 72(3). 272–277. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026